Exceptional Response of Metastatic Chromophobe Renal Cell Carcinoma to Vascular Endothelial Growth Factor (VEGF) Inhibitors: Should Increased VEGF-C Expression Be Used to Guide Treatment?

<div>VEGF expression levels of the exceptional responder. Normalized gene expression levels of VEGF-A (a), VEGF-B (b), and VEGF-C (c) measured in the patient’s tumor (Patient) compared to normal renal tissue (NO), chromophobe RCC (CHR), oncocytoma (ON), clear cell RCC (CC), papillary type 1 RCC (P1), papillary mixed type 1/type 2a RCC (P1.2A), papillary type 2a RCC (P2A), and papillary type 2b RCC (P2B).</div>

Case Reports in Urology

fig3

Figure 3

Figure 3: Exceptional Response of Metastatic Chromophobe Renal Cell Carcinoma to Vascular Endothelial Growth Factor (VEGF) Inhibitors: Should Increased VEGF-C Expression Be Used to Guide Treatment? 

Figure 3 | Exceptional Response of Metastatic Chromophobe Renal Cell Carcinoma to Vascular Endothelial Growth Factor (VEGF) Inhibitors: Should Increased VEGF-C Expression Be Used to Guide Treatment? 